Suppr超能文献

在尼日利亚开展的一项基于社区的筛查中,利用血清前列腺特异性抗原和直肠指检评估前列腺癌的患病率及特征

Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.

作者信息

Ikuerowo Stephen Odunayo, Omisanjo Olufunmilade Adefolarin, Bioku Muftau Jimoh, Ajala Michael Olawale, Mordi Victor Patrick Nonyelim, Esho Julius Olusanmi

机构信息

Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.

出版信息

Pan Afr Med J. 2013 Aug 10;15:129. doi: 10.11604/pamj.2013.15.129.2489. eCollection 2013.

Abstract

INTRODUCTION

Prostate cancer (CaP) is the most commonly diagnosed cancer among Nigerian men but CaP screening is not a common practice. The true burden of the disease in Nigeria is not known. The study was aimed at studying the community burden of CaP in Lagos.

METHODS

During a community-based prostate cancer awareness program in 13 local government areas of Lagos, men aged >40 years had serum total PSA (tPSA) test and digital rectal examination (DRE). Those with abnormal DRE or tPSA >95th percentile of the cohort or both were selected for prostate biopsy (TRPB).

RESULTS

4172 men were screened and complete data was available for 4110 (98.5%). The mean age was 60.8 years. DRE was abnormal in 410 men and was significantly correlated with the age of the patient and tPSA (p<0.001). The tPSA ranged from 0 to 438.3 ng/ml with a median, mean and 95th percentile of 1.5, 2.5 and 10.0 ng/ml respectively. 341 out of the 438 (78%) men selected were subjected to TRBP. Forty-three men had histological diagnosis of CaP, giving an estimated prevalence rate of at least 1.046% or 1046 per 100,000 men of age ≥40. Only 11 (26%) had organ-confined disease while 17 (40%) had locally advanced disease and 15 (35%) men had metastatic disease. The majority of the men, 32 (74%) were reported to have Gleason's score of ≥7.

CONCLUSION

The prevalence rate of CaP among men aged ≥40 years in Lagos is higher than previously reported in hospital-based study. Majority have advanced and high-grade disease.

摘要

引言

前列腺癌(CaP)是尼日利亚男性中最常被诊断出的癌症,但前列腺癌筛查并不常见。该病在尼日利亚的实际负担尚不清楚。本研究旨在调查拉各斯地区前列腺癌的社区负担情况。

方法

在拉各斯13个地方政府辖区开展的一项基于社区的前列腺癌宣传项目中,年龄超过40岁的男性接受了血清总前列腺特异抗原(tPSA)检测和直肠指检(DRE)。那些直肠指检异常或tPSA高于该队列第95百分位数或两者皆有的男性被选作前列腺穿刺活检(TRPB)。

结果

共筛查了4172名男性,4110名(98.5%)有完整数据。平均年龄为60.8岁。410名男性直肠指检异常,且与患者年龄和tPSA显著相关(p<0.001)。tPSA范围为0至438.3 ng/ml,中位数、均值和第95百分位数分别为1.5 ng/ml、2.5 ng/ml和10.0 ng/ml。438名被选男性中有341名(78%)接受了前列腺穿刺活检。43名男性经组织学诊断为前列腺癌,估计患病率至少为1.046%,即每10万名年龄≥40岁的男性中有1046例。只有11名(26%)患有器官局限性疾病,17名(40%)患有局部晚期疾病,15名(35%)患有转移性疾病。据报告,大多数男性(32名,74%)Gleason评分≥7。

结论

拉各斯地区年龄≥40岁男性中前列腺癌的患病率高于此前基于医院研究的报告。大多数患者患有晚期和高级别疾病。

相似文献

5
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.
World J Surg Oncol. 2016 Jun 29;14(1):174. doi: 10.1186/s12957-016-0921-6.

引用本文的文献

2
Prostate cancer diagnosis and management: current practices in Africa a consultant-based survey.
Front Urol. 2025 Mar 17;5:1496951. doi: 10.3389/fruro.2025.1496951. eCollection 2025.
3
Quality of Care and Survival Outcomes Among Patients With Clinically Localized Prostate Cancer in Nigeria.
JCO Glob Oncol. 2025 Mar;11:e2400504. doi: 10.1200/GO-24-00504. Epub 2025 Mar 24.
6
Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria.
Ecancermedicalscience. 2024 Aug 14;18:1740. doi: 10.3332/ecancer.2024.1740. eCollection 2024.
7
Epidemiology of prostate cancer in Nigeria: a mixed methods systematic review.
Cancer Causes Control. 2025 Jan;36(1):1-12. doi: 10.1007/s10552-024-01917-w. Epub 2024 Sep 22.
9
Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based study.
Cancer Treat Res Commun. 2024;39:100811. doi: 10.1016/j.ctarc.2024.100811. Epub 2024 Apr 2.

本文引用的文献

1
Prostate-cancer mortality at 11 years of follow-up.
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
2
Knowledge of prostate cancer screening among native African urban population in Nigeria.
Nig Q J Hosp Med. 2010 Apr-Jun;20(2):94-6. doi: 10.4314/nqjhm.v20i2.58044.
3
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.
4
Burden of prostate cancer in southwestern Nigeria.
Urology. 2010 Aug;76(2):412-6. doi: 10.1016/j.urology.2010.03.020. Epub 2010 May 7.
5
Prostate cancer screening in a Saudi population: an explanatory trial study.
Prostate Cancer Prostatic Dis. 2010 Jun;13(2):191-4. doi: 10.1038/pcan.2009.60. Epub 2010 Jan 12.
6
The burden of prostate cancer in Canada.
Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100.
7
Screening and prostate-cancer mortality in a randomized European study.
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
9
Cancer in Nigeria: a 10-year analysis of the Kano cancer registry.
Niger J Med. 2008 Jul-Aug;17(3):280-4. doi: 10.4314/njm.v17i3.37396.
10
Roots of prostate cancer in African-American men.
J Natl Med Assoc. 2006 Apr;98(4):539-43.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验